Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Motivational Strategies in Batterer Intervention Programs for Offenders With Alcohol/Drug Abuse Problems (IMP-ADAPs) (IMP-ADAPs)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03885349
Recruitment Status : Recruiting
First Posted : March 21, 2019
Last Update Posted : November 4, 2020
Sponsor:
Collaborator:
Ministerio de Sanidad, Servicios Sociales e Igualdad
Information provided by (Responsible Party):
University of Valencia

Brief Summary:
Alcohol and/or drug abuse problems (ADAPs) have been consistently identified in the scientific literature as a risk factor of intimate partner violence against women (IPVAW). Around 50% of IPVAW offenders referred to batterer intervention programs (BIPs) have ADAPs. ADAPs are also one of the main predictors of BIPs dropout. In Spain, the majority of BIPs do not fit the intervention to specific needs or characteristics of IPVAW offenders, such as those with ADAPs. The aim of this research is to assess the effectiveness of a new motivational strategy adapted to IPVAW offenders with ADAPs, aiming to increase treatment adherence and to improve BIPs outcomes. The motivational strategy will include an individualized motivational plan (IMP) developed for each participant with ADAPs (IMP-ADAPs). In these IMPs one of the main aims will be to reduce alcohol and/or drug consumption. The current study will use a randomized control trial. Participants with ADAPs will be allocated to one of two treatment conditions: experimental condition: Standard batterer intervention program (SBIP) plus individualized motivational plan focused in ADAPs (SBIP+ ADAPs-IMP), and control condition: Standard batterer intervention program plus individualized motivational plan (SBIP+IMP). Primary/final outcomes will be recidivism and ADAPs reduction. Secondary/proximal outcomes will include treatment adherence related variables, violence related attitudes and attributions, self-control and psychological adjustment. Outcome variables will be assessed at baseline, at the end of the intervention, and at six months after the intervention will be finished.

Condition or disease Intervention/treatment Phase
Intimate Partner Violence Against Women Alcohol Abuse Drug Abuse Behavioral: SBIP+ ADAPs-IMP Behavioral: SBIP+IMP Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Care Provider)
Primary Purpose: Treatment
Official Title: Motivational Strategies in Batterer Intervention Programs for Intimate Partner Violence Offenders With Alcohol/Drug Abuse Problems: An Experimental Study
Actual Study Start Date : March 4, 2019
Estimated Primary Completion Date : December 2022
Estimated Study Completion Date : December 2022

Arm Intervention/treatment
Experimental: SBIP+ ADAPs-IMP
Experimental condition: Standard batterer intervention program (SBIP) plus individualized motivational plan (IMP) focused in alcohol and/or drugs abuse problems (ADAPs).
Behavioral: SBIP+ ADAPs-IMP
Standard batterer intervention program plus Individualized Motivational Plans adapted to alcohol and/or drug abuse problems. The SBIP consist of 70 hr of a cognitive-behavioral intervention including discussion topics such as sexism, sex roles, and gender equality. The intervention phase consisted of six modules in which different intervention techniques were applied (i.e., group dynamics, roleplaying, videos, training in cognitive restructuring, emotion management skills). The IMP included a set of motivational strategies to increase treatment compliance and motivation for change and had four main strategies: (a) five individual motivational interviews, to identify IPV related personal goals and follow up their achievement (in this case, one of the goals has to be related to ADAPs); (b) three group sessions where participants share their goals; (c) therapists follow-up and reinforcement of participants' goals; and (d) use of retention techniques.

Active Comparator: SBIP+IMP
Control condition: Standard batterer intervention program plus individualized motivational plan (SBIP+IMP)
Behavioral: SBIP+IMP
Standard batterer intervention program plus Individualized Motivational Plans. The SBIP consist of 70 hr of a cognitive-behavioral intervention including discussion topics such as sexism, sex roles, and gender equality. The intervention phase consist of six modules in which different intervention techniques are applied (i.e., group dynamics, roleplaying, videos, training in cognitive restructuring, emotion management skills). The IMP include a set of motivational strategies to increase treatment compliance and motivation for change and has four main strategies: (a) five individual motivational interviews, to identify IPV related personal goals and follow up their achievement; (b) three group sessions where participants share their goals, explain their progress to the group, and receive feedback, support and advice from the group; (c) therapists follow-up and reinforcement of participants' goals; and (d) use of retention techniques.




Primary Outcome Measures :
  1. Change in alcohol abuse problems [ Time Frame: At baseline, at 12 months (end of intervention), and at 18 months (follow-up) ]
    Alcohol Use Disorders Identification Test. Saunders, Aasland, Babor, De la Fuente, & Grant, 1993. Total scale range: 0-20 (Higher values indicate worse outcome).

  2. Change in cannabis abuse problems [ Time Frame: At baseline, at 12 months (end of intervention), and at 18 months (follow-up) ]
    Severity Dependence Scale. Gossop et al., 1995. Total scale range: 0-15 (Higher values indicate worse outcome).

  3. Change in cocaine abuse problems [ Time Frame: At baseline, at 12 months (end of intervention), and at 18 months (follow-up) ]
    Severity Dependence Scale. Gossop et al., 1995. Total scale range: 0-15 (Higher values indicate worse outcome).

  4. Change in self-reported physical intimate partner violence against women [ Time Frame: At baseline, at 12 months (end of intervention), and at 18 months (follow-up) ]
    Self-reported physical violence sub-scale from the Conflict Tacticts Scale. Straus, Hamby, Boney-McCoy y Sugarman, 1996. Total scale range: 0-72 (Higher values indicate worse outcome).

  5. Change in self-reported psychological intimate partner violence against women [ Time Frame: At baseline, at 12 months (end of intervention), and at 18 months (follow-up) ]
    Self-reported psychological violence sub-scale from the Conflict Tacticts Scale. Straus, Hamby, Boney-McCoy y Sugarman, 1996. Total scale range: 0-72 (Higher values indicate worse outcome).

  6. Change in risk of recidivism [ Time Frame: At baseline, at 12 months (end of intervention), and at 18 months (follow-up) ]
    The Spousal Assault Risk Assessment. SARA; Kropp y Hart, 2000. Total scale range: 0-40 (Higher values indicate worse outcome)

  7. Police-reported recidivism [ Time Frame: At 18 months (follow-up) ]
    Ministry of Home Affairs' monitoring system for IPV. This system includes information on further incidents of violence by individuals convicted of IPV and reported by any of the institutions involved in victim protection services. Recidivism will be considered to have occurred when this information appear in the system in the 6 months after completing the intervention.


Secondary Outcome Measures :
  1. Therapeutic alliance [ Time Frame: 4 weeks after the first session of the intervention ]
    Working Alliance Inventory Shortened Observer-rated version (WAI-O-S; Tichenor & Hill, 1989). Total scale range: 0-74 (Higher values indicate better outcome)

  2. Change in motivation [ Time Frame: At baseline, at 6 months, and at 12 months (end of intervention) ]
    Based on the transtheoretical model of change (Prochaska and DiClemente, 1982; Prochaska et al., 1992), therapists will rate participants' stage of change (pre-contemplation, contemplation, preparation, action, and maintenance). Total range: 1-5 (Higher values indicate better outcome).

  3. Change in impulsivity [ Time Frame: At baseline and at 12 months (end of intervention) ]
    Plutchik Impulsivity Scale; Plutchnik y Van Pragg, 1989. Total scale range: 11-44 (Higher values indicate worse outcome)

  4. Change in depressive symptomatology [ Time Frame: At baseline and at 12 months (end of intervention) ]
    Spanish reduced version of the Center for Epidemiology Studies-Depression Scale; Herrero y Gracia, 2007. Total scale range: 7-28 (Higher values indicate worse outcome)

  5. Change in self-esteem [ Time Frame: At baseline and at 12 months (end of intervention) ]
    Rosenberg Self-Esteem Scale. Rosenberg, 1965. Total scale range: 10-40 (Higher values indicate better outcome)

  6. Attributions of Responsibility [ Time Frame: At baseline and at 12 months (end of intervention) ]
    Intimate Partner Violence Responsibility Atribution Scale. Lila, Oliver, Catalá-Miñana, Galiana y Gracia, 2014. Three sub-scales: responsibility attribution to the legal system (sub-scale range: 4-20), responsibility attribution to the victim (sub-scale range: 4-20), and responsibility attribution to the offender personal context (sub-scale range: 4-20). Higher values indicate worse outcome.

  7. Change in perceived severity of intimate partner violence against women [ Time Frame: At baseline and at 12 months (end of intervention) ]
    Severity Perception of Intimate Partner Violence Against Women Scale. Gracia, García y Lila (2011). Total scale range: 8-80 (Higher values indicate better outcome)

  8. Change in acceptability of intimate partner violence against women [ Time Frame: At baseline and at 12 months (end of intervention) ]
    Acceptability of Intimate Partner Violence Against Women Scale. Martín-Fernández, Gracia, Marco, Vargas, Santirso and Lila (2018). Total scale range: 0-40 (Higher values indicate worse outcome)

  9. Change in benevolent sexism [ Time Frame: At baseline and at 12 months (end of intervention) ]
    Ambivalent Sexism Inventory. Glick y Fiske, 1996. Two sub-scales: Benevolent sexism (sub-scale range: 0-55) and Hostile sexism (sub-scale range: 0-55). Higher values indicate worse outcome



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Males convicted of IPV against their partner or ex-partner
  • Alcohol and/or drugs abuse problems

Exclusion Criteria:

  • No current severe psychological disorders

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03885349


Contacts
Layout table for location contacts
Contact: Elena Terreros, PhD +3463030607983918 elenaterreros@gmail.com

Locations
Layout table for location information
Spain
Faculty of Psychology Recruiting
Valencia, Spain, 46010
Contact: Elena Terreros, PhD         
Sponsors and Collaborators
University of Valencia
Ministerio de Sanidad, Servicios Sociales e Igualdad
Investigators
Layout table for investigator information
Principal Investigator: Marisol Lila, PhD University of Valencia
Layout table for additonal information
Responsible Party: University of Valencia
ClinicalTrials.gov Identifier: NCT03885349    
Other Study ID Numbers: H1537520365110
First Posted: March 21, 2019    Key Record Dates
Last Update Posted: November 4, 2020
Last Verified: November 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University of Valencia:
Intimate partner violence
Alcohol
Drug
Batterer intervention programs
Additional relevant MeSH terms:
Layout table for MeSH terms
Alcoholism
Substance-Related Disorders
Alcohol-Related Disorders
Chemically-Induced Disorders
Mental Disorders